FAQ
Log In
Friday 22nd September 2017
News
 › 
 › 

Human sensitivity to radiation

15th March 2013

The Health Protection Agency has issued a new report on human sensitivity to radiation.

The HPA’s independent Advisory Group on Ionising Radiation (AGIR) says that evidence suggests that the risk of developing cancer or tissue damage after exposure to ionising radiation varies among people because of genetic and lifestyle factors.

The group’s report says, in particular, that there is strong evidence that smoking substantially increases the risk of developing lung cancer after exposure to ionising radiation.

It added that this was particularly marked in people exposed to radon gas.

Genetic factors could also affect the way people react to ionising radiation, however, the HPA suggests that further research is still needed in this area to confirm this and identify all the genes responsible.

The findings, says the HPA, could have implications for advice given to smokers who undergo radiotherapy.

AGIR chairman Professor Bryn Bridges said: “Identification and understanding of the various factors that contribute to radiosensitivity is improving but remains incomplete. There is currently no simple predictive test of individual radiosensitivity, although such tests may be available in the future.”

He added that now is the right time to consider how knowledge of lifestyle factors such as smoking might be incorporated into occupational, medical and public radiation protection.

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Human sensitivity to radiation
Author: Mark Nicholls
Article Id: 23910
Date Added: 15th Mar 2013

Sources

Health Protection Agency

Recent Related Articles

3-D printing of human organs breakthrough

GSK's new chief executive ditches over 30 drug research projects in strategic review

Actions

Add to scrapbook
Show Comments
Add comment
Find all related articles

Tags

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2017